Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Erttmann

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Klinische Padiatrie|May 1, 1988
[Antineoplastic effectiveness and toxicity of idarubicin (4-demethoxy-daunorubicin) in recurrent acute leukemias in childhood]R Erttmann, U Bode, N Erb, et al.
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|January 1, 1986
[Effect of a local surgical procedure on the incidence of metastases following neoadjuvant chemotherapy of osteosarcoma]K Winkler, G Beron, R Kotz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian studyK Winkler, G Beron, R Kotz, et al.
Klinische Padiatrie|July 1, 1992
[Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study]R Ludwig, A Weirich, R Pötter, et al.
Bone Marrow Transplantation|February 1, 1996
Use of cryopreserved bone marrow in unrelated allogeneic transplantationM Stockschläder, W Krüger, A tom Dieck, et al.
Klinische Padiatrie|May 1, 1988
[Myeloablative chemo- and radiotherapy with autologous and allogenic bone marrow reconstitution in children with metastatic neuroblastoma]F Berthold, C Bender-Götze, R Dopfer, et al.
Cancer|October 15, 1990
Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86)K Winkler, S Bielack, G Delling, et al.
Klinische Padiatrie|August 8, 2002
[Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG]F Graf Finckenstein, T Zabelina, M Dürken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patientsF Berthold, B Hero, H Breu, et al.
Bone Marrow Transplantation|October 14, 2008
Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005M Sauer, B Meissner, D Fuchs, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Klinische Padiatrie|May 1, 1988
[Antineoplastic effectiveness and toxicity of idarubicin (4-demethoxy-daunorubicin) in recurrent acute leukemias in childhood]R Erttmann, U Bode, N Erb, et al.
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|January 1, 1986
[Effect of a local surgical procedure on the incidence of metastases following neoadjuvant chemotherapy of osteosarcoma]K Winkler, G Beron, R Kotz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian studyK Winkler, G Beron, R Kotz, et al.
Klinische Padiatrie|July 1, 1992
[Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study]R Ludwig, A Weirich, R Pötter, et al.
Bone Marrow Transplantation|February 1, 1996
Use of cryopreserved bone marrow in unrelated allogeneic transplantationM Stockschläder, W Krüger, A tom Dieck, et al.
Klinische Padiatrie|May 1, 1988
[Myeloablative chemo- and radiotherapy with autologous and allogenic bone marrow reconstitution in children with metastatic neuroblastoma]F Berthold, C Bender-Götze, R Dopfer, et al.
Cancer|October 15, 1990
Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86)K Winkler, S Bielack, G Delling, et al.
Klinische Padiatrie|August 8, 2002
[Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG]F Graf Finckenstein, T Zabelina, M Dürken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1996
The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patientsF Berthold, B Hero, H Breu, et al.
Bone Marrow Transplantation|October 14, 2008
Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005M Sauer, B Meissner, D Fuchs, et al.
Pageof 9